QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 251 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $134,810,000 | +45.3% | 1,457,399 | +2.0% | 3.20% | +37.6% |
Q1 2014 | $92,775,000 | +23.0% | 1,428,833 | +3.1% | 2.33% | +18.0% |
Q4 2013 | $75,436,000 | -6.7% | 1,385,417 | -0.6% | 1.97% | -11.5% |
Q3 2013 | $80,815,000 | +27.3% | 1,393,349 | -0.3% | 2.23% | +12.1% |
Q2 2013 | $63,479,000 | – | 1,396,996 | – | 1.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 3,296,660 | $149,800,000 | 34.05% |
Valiant Capital Management, L.P. | 913,693 | $41,518,000 | 4.98% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 366,625 | $16,659,000 | 4.35% |
Freshford Capital Management, LLC | 575,000 | $26,128,000 | 3.87% |
Palo Alto Investors LP | 696,297 | $31,640,000 | 3.73% |
RIVULET CAPITAL, LLC | 100,000 | $4,544,000 | 3.62% |
CAPITAL MANAGEMENT CORP /VA | 190,135 | $8,640,000 | 3.59% |
Consonance Capital Management LP | 200,000 | $9,088,000 | 3.23% |
DIALECTIC CAPITAL MANAGEMENT, LP | 407,400 | $18,513,000 | 2.70% |
Freestone Capital Holdings, LLC | 268,738 | $12,211,000 | 2.50% |